The Meals and Drug Administration (FDA) has granted 510(ok) clearance for IQ-UIP, a synthetic intelligence (AI)-powered software program for enhancing computed tomography (CT) analysis of normal interstitial pneumonia (UIP).
Leveraging deep studying know-how, IQ-UIP supplies automated evaluation of standard CT scans with fast detection of UIP patterns similar to honeycombing and subpleural fibrosis, in keeping with 4DMedical, the developer of IQ-UIP.
Emphasizing that greater than 50 p.c of UIP is initially misdiagnosed, 4DMedical famous the situation’s non-specific symptomatology could mimic different situations similar to bronchial asthma and power obstructive pulmonary illness (COPD).
Along with a fast analysis of UIP, which is characterised by power irritation and progressive lung fibrosis, 4DMedical mentioned IQ-UIP supplies automated referral workflows for specialists, facilitating well timed look after a situation that has a median survival of 1 to 2 years after analysis.